TGA backs consumer adverts for ulipristal in Australia

Pharmacy News, 19 May, 2017

The TGA has agreed that consumer advertising should be allowed for the emergency contraceptive ulipristal.

This will help increase public awareness and access to ulipristal (branded EllaOne) and therefore reduce unplanned pregnancies, says the TGA.

 

 

VAC announces $100,000 for PREPX trial [for HIV prevention]

Gay News Network, Wednesday 18 January 2017

The Victorian AIDS Council has announced it will give an additional $100,000 to the PrEPX trial to fund access to pre-exposure prophylaxis for HIV (PrEP) for 600 Victorians at risk.

VAC’s announcement comes months after PrEPX reached capacity for men living in
metropolitan Melbourne. The VAC said there is already a substantial waiting list for those wishing to access PrEP as part of the trial.

Breaking news: SA announces HIV prevention drug trial

Jay Weatherill MP, Nat Cook MP, Wednesday, November 29, 2016

South Australians at high risk of contracting HIV will have access to the latest preventative technology study, as part of a State Government commitment announced today.

Pre-exposure prophylaxis or PrEP is the latest prevention therapy in the fight against HIV. Under a PrEP access trial, eligible South Australians who don’t have HIV and who are at high risk of acquiring HIV may be prescribed a daily oral pill which, when taken consistently, has been shown to be effective in preventing HIV.

South Australia will commence negotiations with other states currently leading PrEP access trials.

Read more hiv-prevention-drug-trial

 

 

 

Rescheduling of ulipristal acetate (EllaOne®) in Australia

SHine SA, October 2016

SHine SA and Family Planning Alliance Australia put in submissions to the TGA for the rescheduling of ulipristal acetate (EllaOne®), a new emergency contraceptive pill in Australia.

The rescheduling is from prescription-only to Schedule 3 (available in pharmacies with a pharmacy consultation). This has now been approved, to take place from February 2017.

This is an important access issue.

EllaOne® emergency contraception has also been added to the SHine SA formulary.

Access TGA information about ulipristal acetate (including links to the public submissions) here 

Blood donor restrictions for gay men should be removed, Victorian Government says

ABC, 7.10.16

he Victorian Government has called on its federal counterpart to end the ban on men who have sex with men from donating blood.

Key points:

  • Current restrictions prevent men from donating blood within 12 months of having sex with another man
  • State and federal ministers have agreed to review the national donation policy in 2017
  • According to the Red Cross, the risk of infection from a blood donation is less than one in 1 million

 

Read more here

AFAO publishes Australian PrEP roundup

 Australian Federation of AIDS Organisations (AFAO), 23 August, 2016

Following the Pharmaceutical Benefits Advisory Committee (PBAC) decision not to recommend funding PrEP through the Pharmaceutical Benifits Scheme (PBS), AFAO has produced an Australian PrEP roundup paper to sustain advocacy efforts and to raise awareness about current options for accessing PrEP around the country.

In releasing their decision, the PBAC has said they accept the importance of PrEP but were unable to recommend it for a number of  reasons, including the cost-effectiveness of the price submitted by Gilead Sciences.

Despite this setback, AFAO will continue with community advocacy to have Gilead Sciences resubmit its application as soon as possible. Interim PrEP access arrangements remain crucial in the meantime.

Download Australian PrEP roundup